EUVIMEDOpdag EUVIMED
Crossref

Phenethyl Isothiocyanate Suppresses Hepatocellular Carcinoma Progression and Immune Evasion via ZNF652 Regulation of PD ‐ L1

Dongxue Ren, Jinyi Wu, Jiayu Zhu, Chunfeng Xie iD, Caiyun Zhong, Hui Cao, Hongyu Han iD, Jianyun Zhu

Phytotherapy Research · 2026-06 · 40 (6) · 3777-3793

DOI: 10.1002/ptr.70299 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-04-15. Written by Dongxue Ren and 7 co-authors. Institution: Department of Esophageal Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China. Major MEDLINE topics: Isothiocyanates, Liver Neoplasms, B7-H1 Antigen, Carcinoma, Hepatocellular. 71 references. Funded by: National Natural Science Foundation of China, the Health Science and Technology Development Foundation of Nanjing.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma (HCC) remains limited, with programmed death receptor‐1 (PD‐1)/programmed cell death 1 ligand 1 (PD‐L1) blockade effective in only some patients. Here, we report that phenethyl isothiocyanate (PEITC), a bioactive phytochemical, demonstrated promising anticancer potential in HCC by inhibiting cell proliferation and migration, while promoting apoptosis in vitro. We also observed that PEITC significantly suppressed tumorigenesis of HCC in vivo. Importantly, PEITC downregulated PD‐L1 expression in a concentration‐dependent manner and enhanced the sensitivity of HCC cells to T cell‐mediated cytotoxicity. When combined with anti‐PD‐L1 antibody, PEITC improved the efficacy of immunotherapy. Additionally, bioinformatics and experimental validation revealed that zinc finger protein 652 (ZNF652), a transcription factor, was upregulated and positively correlated with PD‐L1 expression in HCC. Mechanistically, ZNF652 bound to the promoter of PD‐L1 to activate its transcription. ZNF652 overexpression partially reversed the suppressive effects of PEITC on PD‐L1 expression and T cell cytotoxicity, while ZNF652 knockdown enhanced these effects in vitro. These findings indicated that PEITC suppresses HCC progression and immune evasion by downregulating PD‐L1 via modulation of ZNF652, providing a basis for its potential use in HCC immunotherapy.

Subjects

MeSH terms (MEDLINE)

IsothiocyanatesLiver NeoplasmsB7-H1 AntigenCarcinoma, HepatocellularHumansAnimalsCell ProliferationCell Line, TumorMiceApoptosisGene Expression Regulation, NeoplasticDisease ProgressionCell Movement

Author keywords

PD‐L1ZNF652hepatocellular carcinomaimmune escapephenyl isothiocyanate

Substances

IsothiocyanatesB7-H1 AntigenCD274 protein, humanphenethyl isothiocyanate

Authors and institutions

  • Department of Esophageal Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.
  • Liver Disease Department of Integrative Medicine, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
  • Department of Nutrition and Food Safety, School of Public Health, Nanjing Medical University, Nanjing, China.
  • Department of Thoracic Surgery, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Clinical Nutrition, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Medical Science and Technology Innovation Center, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China.

ORCID profiles: Chunfeng Xie, Hongyu Han

Funding

  • National Natural Science Foundation of China
  • the Health Science and Technology Development Foundation of Nanjing

Cite

APA

Ren, D., Wu, J., Zhu, J., Xie, C., Zhong, C., Cao, H., Han, H., & Zhu, J. (2026). Phenethyl Isothiocyanate Suppresses Hepatocellular Carcinoma Progression and Immune Evasion via ZNF652 Regulation of PD ‐ L1. Phytotherapy Research, 40(6), 3777-3793. https://doi.org/10.1002/ptr.70299

Vancouver

Ren D, Wu J, Zhu J, Xie C, Zhong C, Cao H, et al. Phenethyl Isothiocyanate Suppresses Hepatocellular Carcinoma Progression and Immune Evasion via ZNF652 Regulation of PD ‐ L1. Phytotherapy Research. 2026;40(6):3777-3793. doi:10.1002/ptr.70299

BibTeX
@article{Ren2026,
  author = {Ren, Dongxue and Wu, Jinyi and Zhu, Jiayu and Xie, Chunfeng and Zhong, Caiyun and Cao, Hui and Han, Hongyu and Zhu, Jianyun},
  title = {Phenethyl Isothiocyanate Suppresses Hepatocellular Carcinoma Progression and Immune Evasion via ZNF652 Regulation of PD ‐ L1},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {6},
  pages = {3777--3793},
  doi = {10.1002/ptr.70299}
}
Start for free →